As of Oct 02
| +1.42 / +2.25%|
The 14 analysts offering 12-month price forecasts for Charles River Laboratories International Inc have a median target of 78.00, with a high estimate of 88.00 and a low estimate of 60.00. The median estimate represents a +20.91% increase from the last price of 64.51.
The current consensus among 19 polled investment analysts is to Hold stock in Charles River Laboratories International Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.